|
|
|
| Webinar: Enhancing Gene Editing Outcomes and Safety for Clinical Translation with Next Generation Vectors | Discover how smarter plasmid design can strengthen gene editing outcomes from bench to bedside. This webinar explores how streamlined DNA constructs can improve editing efficiency, support cell viability, and enhance long-term expression. Learn how reducing unnecessary vector components may boost consistency, safety, and downstream performance, while offering insight into the Nanoplasmid™ approach for next-generation therapeutic development. Click here to learn more. |
|
|
|
Webinar | AGC Biologics | Assimilate how CDMOs can leverage strategic agility, scale flexibility, and overcome challenges to drive success in a rapidly evolving pharmaceutical landscape. |
|
|
|
Webinar | Adare Pharma Solutions | Delve into how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes. |
|
|
|
Webinar | KBI Biopharma | Our integrated solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and strategies. |
|
|
|
Webinar | Abzena | Strategic planning in early-phase biologics accelerates clinical progress, reduces risk, and lays the groundwork for scalable, compliant manufacturing and successful commercialization. |
|
|
|
Video | Outsourced Pharma | This segment of the Outsourced Pharma Live event, "Clinical Supply Therapy: Lowering Risk and Your Blood Pressure," addresses critical lessons learned during the pandemic on supply chain execution. |
|
|
|
Webinar | Samsung Biologics | Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes. |
|
|
|
|
| Outsourced Pharma Capabilities Update | This online event series connects biopharma companies with CDMOs to explore capabilities across biologics production, HPAPI manufacturing, and drug–device combination development. Through concise presentations, CDMOs showcase expertise in development, scale-up, containment, and GMP manufacturing. Attendees gain insights into technologies, regulatory expectations, and partnership models, while engaging directly with providers to evaluate outsourcing options and identify the best-fit partners for advancing and commercializing complex therapies. Click to learn more. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
